Up to 36 months durability of functional cure in response to bepirovirsen therapy in B-Clear Not-on-NA responders: Results from the B-Sure study

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
Barcelona, Spain
May 27-30, 2026


Up to 36 months durability of functional cure in response to bepirovirsen therapy in B-Clear Not-on-NA responders: Results from the B-Sure study

	EASL 2026 May 26-30 Barcelona Seng-Gee Lim1, Download the PDF here